Autologous Bone Marrow Stem Cells in Middle Cerebral Artery Acute Stroke Treatment.

Completed

Phase 1/2 Results N/A

Summary of Purpose

The aim of the study is to determine the safety and efficacy on an autologous CD34+ subset bone marrow stem cell infusion into the middle cerebral artery in patients who have suffered acute middle cerebral artery stroke.

Read More →

Trial Milestones

The following dates are available for this trial. Trial information last updated on 27 November 2011.

1 Sep 2008 28 Sep 2008 1 Aug 2011 1 Aug 2011 1 Nov 2011 Unavailable
Start Date First Received 1st Completion Completion Verification Results

Trial Design

  • Allocation: Non-Randomized
  • Masking: Single Blind (Outcomes Assessor)
  • Purpose: Treatment
  • Endpoint: Safety/Efficacy Study
  • Intervention: Parallel Assignment

Contacts

Not available